GlassScriptPhysician profile
Charles A Kean
NPI 1467467902
$1,057.77
in general payments reported to CMS, 2019-2025
12 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $80.67 · 2021: $198 · 2022: $136 · 2023: $116 · 2024: $94.92 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $447.28 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Team 1, LLC | $193.68 | 2024-2025 | |
| Advanced Oxygen Therapy INC. | $106.39 | 2020-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $91.65 | 2019-2024 | Grafix Pl, Renasys Go V2 Home |
| Tactile Systems Technology INC | $61.13 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Acera Surgical, INC. | $28.22 | 2021-2022 | |
| Covidien LP | $27.25 | 2020 | |
| Arthrosurface Incorporated | $26.58 | 2019 | |
| Stryker Corporation | $26.43 | 2023 | Easyfuse |
| Hydrofera LLC | $19.08 | 2025 | Hydrofera Blue |
| Lemaitre Vascular, INC. | $16.23 | 2025 | Restoreflow |
| Biotissue Holdings INC. | $13.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.